RAC racura oncology ltd
Add to My Watchlist 2.70% ! $1.99

Celgene is making 50% of their profits of bendamustine. And,...

  1. biotechtrader73
    1 Posts.
    clock Created with Sketch.
    14/04/18
    05:59
    Post #: 32451118
    Celgene is making 50% of their profits of bendamustine. And, it's going off patent. Maybe they should target Race Oncology for acquistion.
    RAC Price at posting: 34.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS 'Strongest environment in a generation' for defence stocks
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$1.99 		Change
-0.055(2.70%) 		Mkt cap ! $398.9M
Open High Low Volume
$2.04 $2.09 $1.95 149.8K

Buyers (Bids)

Vol. Price($)
250 $1.98
 

Sellers (Offers)

Price($) Vol.
$1.99 22228
Last trade - 16.10pm 29/07/2026 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.